Overview Fundamentals API Earnings EOD API Sample Code Pricing

Senti Biosciences Inc (SNTI NASDAQ) stock market data APIs

$2.84 -0.05(-1.7%) as of September 9, 2024
Price chart is built with Anychart

Senti Biosciences, Inc. operates as a preclinical biotechnology company that develops next-generation cell and gene therapies engineered with its gene circuit platform technologies for various diseases. Its lead product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated OR+NOT off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma. It also develops SENTI-401, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate colorectal cancer/CRC cells. In addition, the company develops Tumor-Associated Antigen and Protective Antigen Paired Discovery Platform to select and validate NOT GATE antigen candidates and identify tumor-associated antigens in cancer cells. The company has a strategic collaboration with Celest Therapeutics (Shanghai) Co. Ltd for the clinical development of SENTI-301A to treat solid tumors. Senti Biosciences, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.

Senti Biosciences Inc Financial Data Overview

2.89
2.84
-
3.1
2.84
1.5201-8.48
13 233 K
4 579 K
338 K
-2.4503
2.774
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'SNTI',
Type: 'Common Stock',
Name: 'Senti Biosciences Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG010WX7ZB3',
ISIN: NULL,
CUSIP: NULL,
CIK: '1854270',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2022-06-09',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Senti Biosciences Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 338 K
  • EBITDA -56 604 000
  • Earnings Per Share -17.54
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Senti Biosciences Inc Earnings via APIs

  • Latest Release 2024-08-09
  • EPS/Forecast NaN

Get Senti Biosciences Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com